Ipromlimab and Tuvonralimab Combined With Albumin-Bound Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Clinical trial NCT07374003 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07374003
- Sponsor
- Sun Yat-sen University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-17
- Primary completion
- 2029-06-20
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.